person · Reporting owner
Eichenbaum Kenneth D.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FEMASYS INCFEMY · Entity 7510 | Director | June 24, 2026 | August 12, 2026 |
| InfuSystem Holdings, IncINFU · Entity 6163 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FEMASYS INC
Report date June 24, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.67 · Expires 2036-06-24 | Direct | 880 |
Reported balance
After 2026-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-24 · Grant · Acquired 880 · Balance 880 F1: The shares underlying the stock option vest one year from the date of grant, assuming continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the stock option vest one year from the date of grant, assuming continued service.
InfuSystem Holdings, Inc
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.37 · Expires 2036-05-12 | Direct | 24,890 |
Reported balance
After 2026-05-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-12 · Grant · Acquired 24,890 · Balance 24,890 F1: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027. |
| Common StockSEC Table I · non-derivative | Direct | 6,000 |
Reported balance
Holding disclosure · report date 2026-05-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 6,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Aug 12, 2026 01:09 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 880 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001140361-26-032349 · form4.xml · derivative · entry 1 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880 Underlying: Common Stock · 880 shares Expires 2036-06-24 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| May 12, 2026 Filed May 14, 2026 22:28 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 24,890 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001628280-26-035255 · wk-form4_1778797729.xml · derivative · entry 2 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,890 Underlying: Common Stock · 24,890 shares Expires 2036-05-12 F1 · derivative.exercise_date: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027. Read SEC document |
| March 19, 2026 Filed Mar 27, 2026 21:00 UTC | FEMASYS INC FEMY · Entity 7510 | GrantSeries D-1 Warrants · Derivative | 102,366 | Not disclosed Strike: $0.58 | Not disclosed |
DisclosureSEC source: 0001140361-26-011786 · form4.xml · derivative · entry 1 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,366 Underlying: Common stock, par value $0.001 per share · 102,366 shares Expires 2036-03-19 F1 · derivative.exercise_price: Holder may, at its option, exercise the Series D-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.58 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series D-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions. F3 · price: The reported securities were issued to the reporting person in a private placement as consideration in connection with that certain Omnibus Amendment and Consent Agreement, dated as of March 19, 2026 by and among the Company, the reporting person and the other parties thereto. F2 · derivative.underlying_shares: The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 22:38 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 35,200 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001140361-26-010604 · form4.xml · derivative · entry 1 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,200 Underlying: Common Stock · 35,200 shares Expires 2036-03-18 F1 · derivative.exercise_date: The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on March 18, 2027, assuming continued service. Read SEC document |
| May 28, 2025 Filed May 28, 2025 20:24 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,000 | $5.18 | $10,360.00 |
DisclosureSEC source: 0001628280-25-028163 · wk-form4_1748463883.xml · nonDerivative · entry 2 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 16, 2025 Filed May 20, 2025 22:55 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 39,588 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026958 · wk-form4_1747781722.xml · derivative · entry 2 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,588 Underlying: Common Stock · 39,588 shares Expires 2035-05-16 F1 · derivative.exercise_date: The option, representing the right to purchase 39,588 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026. Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 22:19 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 4,000 | $5.89 | $23,560.00 |
DisclosureSEC source: 0001628280-24-041314 · wk-form4_1727302782.xml · nonDerivative · entry 1 Eichenbaum Kenneth D. · CIK 0002024404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.